UK’s Health Secretary announces 10-year plan to tackle dementia
  Author: Mateen Dalal

The UK Health and Social Care Secretary, Sajid Javid, has reportedly announced a novel 10-year plan to effectively tackle dementia and to increase funding in research to get a better understanding of neurodegenerative ...

Read More >>
Starbucks to cover abortion related travel expenses for workers
  Author: Mateen Dalal

Starbucks has reportedly announced that it would start covering all eligible travel expenditures for the workers seeking gender-affirming surgical procedures or abortions. As per ...

Read More >>
Legato opens 80 new jobs in its Limerick Research & Development hub
  Author: Nikita Chaurasia

The global capability center of a leading U.S. health care insurance company, Legato Health Technologies is planning to build an additional 80 posts at its Limerick facility. ...

Read More >>
Adani Group to invest $4 billion in healthcare to curb challenges
  Author: Mateen Dalal

Gautam Adani, Chairperson of the Adani Group, is reportedly investing enormously in the hospital and healthcare industry along with diagnostic chains and digital and offline among additional assets to set two people di...

Read More >>
Arine partners with Amazon Web Services (AWS) to curb health inequities
  Author: Mateen Dalal

Arine, an intelligent medication optimization firm, has recently announced that it has been chosen for a $40 million Amazon Web Services’ (AWS) global program backing companies that are building solutions to mini...

Read More >>
Magellan partners with Concert Genetics to enhance genetic testing
  Author: Nikita Chaurasia

Magellan Healthcare, a leading behavioral health and specialty segment of Magellan Health, Inc., has announced a new partnership with Concert Genetics, a managed services and software firm that offers the digital infra...

Read More >>
Emeritus unveils Emeritus Healthcare to curb global employee crisis
  Author: Nikita Chaurasia

Emeritus, an international leader in making top-quality education affordable and accessible to companies, individuals, and governments across the world, has announced the launch of Emeritus Healthcare. ...

Read More >>
GripAble secures $11Mn funding to offer musculoskeletal & neuro rehab
  Author: Nikita Chaurasia

GripAble, a leading London headquartered digital healthcare start-up offering rehabilitation program to people with musculoskeletal and neurological conditions, has announced securing an investment of $11 million in a ...

Read More >>
Sri Lanka fears catastrophic death toll due to medical supply shortages
  Author: Nikita Chaurasia

Sri Lanka is witnessing its worst economic crisis seen in decades forcing the country to survive amidst shortage of fuel and other essential commodities Sri Lanka M...

Read More >>
TabletWise.net unveils multilingual medicine platform for India
  Author: Nikita Chaurasia

TabletWise.net, one of the leading health information platforms, has announced the launch of India’s biggest consumer medicine websites in Tamil, Hindi, and Telugu. As per sou...

Read More >>
South Korea eases restrictions amid the slowing omicron spread
  Author: Nikita Chaurasia

South Korea is planning to ease some of its pandemic restrictions starting the next week as officials showcase hope that the vilest of its omicron outbreak has gone. The limit on pr...

Read More >>
AstraZeneca sets 'Ambition Zero Carbon' plan to remove emissions by 2025
  Author: Mateen Dalal

AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, has recently recognized how important it is to push the limitations of science and provide life-changing medicines in record time....

Read More >>
Experts warn risk of public health catastrophe in Ukraine amid war
  Author: Mateen Dalal

Amid the shelling by the Russian army in Ukraine, a convoy of five vans has been reported to slowly retrieve from the war hit capital Kyiv, moving towards Chernihiv, the northeast part of the country with generators, f...

Read More >>
CBRE inaugurates special education and health care services in India
  Author: Nikita Chaurasia

CBRE South Asia has announced the launch of specialized business services to promote the education and health related real estate services across India, creating enormous investment opportunities and growth potential....

Read More >>
WHO suggests Ukraine to destroy disease-causing pathogens amid war
  Author: Mateen Dalal

As the Russia-Ukraine war gains momentum, the World Health Organization has advised Ukraine to destroy the pathogens which cause diseases, stored in the country’s public health laboratories. ...

Read More >>
KTR Capital launches crypto token HMA; aims to revolutionize healthcare
  Author: Mateen Dalal

KTR Capital, a leading investment managing fund specializing in the health care segment, has announced its plans to revamp the healthcare segment by making investments in the U.S stock market of medical equipment, phar...

Read More >>
CGH unveils first home-based prehabilitation program for cancer patients
  Author: Mateen Dalal

In a latest development across the medical fraternity, patients recently diagnosed with cancer and awaiting surgery can conduct their pre-operation prehabilitation at home, with the introduction of Changi General Hospi...

Read More >>
Omicron variant may impact global growth & inflation: Rating agencies
  Author: Nikita Chaurasia

Moody's Investors Service and Fitch Ratings have reported that the COVID-19 Omicron variant could significantly dampen the global growth outlook while also pushing prices higher, after the World Health Organization...

Read More >>
Israel begins inoculating young children amidst surging COVID-19 cases
  Author: Nikita Chaurasia

Israel has begun vaccinating 5 to 11 year old children with the Pfizer/BioNtech vaccine, an effort to control the latest spike in Coronavirus infections. The country was hit by the&...

Read More >>
Wockhardt, RDIF to produce Sputnik V, Sputnik Light COVID-19 vaccines
  Author: Mateen Dalal

Pharmaceutical firm, Wockhardt has recently announced that it has teamed with the Russian Direct Investment Fund (RDIF) to produce and supply COVID-19 vaccines Sputnik V and Sputnik Light. ENSO Healthcare, RDIF's c...

Read More >>
Thailand might order 200,000 courses of anti-COVID drugs from Merck
  Author: Mateen Dalal

Thailand’s government is reportedly in talks with U.S. Pharmaceutical giant Merck & Co. to order 200,000 courses of the company’s experimental anti-viral COVID pills. ...

Read More >>
France suspends 3000 healthcare workers for failing vaccine compliance
  Author: Nikita Chaurasia

Several care homes, hospitals, and health centers across France have reportedly suspended approximately 3,000 workers for failing to comply with COVID-19 vaccination mandates. This news comes after several EU countries...

Read More >>
European Medicines Agency studying the need for COVID-19 booster dose
  Author: Nikita Chaurasia

The European Medicines Agency has advanced the evaluation on the need to recommend a booster dose of the COVID-19 vaccine made by Pfizer-BioNTech. The EU drug regulator stated that ...

Read More >>
WHO asks high-income countries to stop giving COVID-19 booster shots
  Author: Nikita Chaurasia

In a bid to bridge the global supply gap, the World Health Organization (WHO) has called on the high-income nations to halt the distribution of COVID-19 booster jabs. Dr. Tedros Adhanom Ghebreyesus, the head of WHO sta...

Read More >>
CDC warns of severely high COVID-19 transmission rate in U.S. counties
  Author: Nikita Chaurasia

The United States Centers for Disease Control and Prevention (CDC) has warned that 66.6% of the total U.S. counties still have a high risk of acquiring or transmitting COVID-19. The regulatory body has also updated its...

Read More >>
Australian scientists develop non-invasive testing strips for diabetics
  Author: Nikita Chaurasia

Some Australian scientists have recently revealed the development of a new form of blood sugar testing for diabetic patients, which is a non-invasive and pain-free strip that examines glucose levels through saliva....

Read More >>
Administering Pfizer jab after AstraZeneca’s could be effective: Oxford
  Author: Nikita Chaurasia

A study conducted by the Oxford University called Com-COV has found that if the Pfizer COVID-19 dose is administered four weeks after a shot of the AstraZeneca vaccine, it will result in better immune responses rather ...

Read More >>
Breckenridge Pharmaceutical receives FDA approval for anti-cancer drug
  Author: Nikita Chaurasia

According to reliable sources, Natco Pharma’s marketing partner Breckenridge Pharmaceutical Inc. has obtained approval from U.S. Food and Drug Administration (USFDA), for its anti-cancer drug Carfilzomib Vials....

Read More >>
Valneva to start final phase trials of its COVID-19 vaccine this month
  Author: Nikita Chaurasia

In recent developments, French biotechnology organization Valneva SE has announced positive results in the early-stage clinical trials of its inactivated COVID-19 vaccine candidate, VLA2001. Following the recent develo...

Read More >>
Abbott receives EUA for its rapid COVID-19 antigen self-test BinaxNOW
  Author: Nikita Chaurasia

Individuals with or without COVID-19 signs can get BinaxNOW without the need for a prescription. Abbott is reportedly planning to deliver BinaxNOW...

Read More >>
Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
  Author: Nikita Chaurasia

According to reliable sources, Massachusetts-headquartered clinical stage biopharmaceutical company, Syndax Pharmaceuticals Inc. has revealed an updated data from its Phase 1 trial of its patent axatilimab. The company...

Read More >>
WHOOP, Field Trip partner to study impact of psychedelic therapies
  Author: Nikita Chaurasia

WHOOP Inc., a prominent provider of health tracking and monitoring services, has reportedly announced a partnership with Field Trip Health Ltd., leader in development and delivery of psychedelic therapies. According to...

Read More >>
NovaBay Pharmaceuticals unveils its skincare product Clinical Reset
  Author: Nikita Chaurasia

According to reliable sources, California-headquartered clinical-stage biopharmaceutical company, NovaBay Pharmaceuticals, Inc., has reportedly announced the consumer launch of its FDA-approved skincare product, CelleR...

Read More >>
Eli Lilly and Company’s bamlanivimab wins EUA for COVID-19 treatment
  Author: Nikita Chaurasia

Eli Lilly and Company has reportedly received an EUA (emergency use authorization) by the U.S. FDA for its monoclonal antibody vaccine, bamlanivimab. ...

Read More >>
NHS on standby for possible COVID-19 vaccine rollout in December
  Author: Nikita Chaurasia

NHS (National Health Service), a U.K.-based government-funded health care system, has reportedly been told to prepare for potential COVID-19 vaccine rolls outs by December 2020. Sou...

Read More >>
London’s gearing up to deliver Covid-19 vaccine as early as next week
  Author: Nikita Chaurasia

The George Eliot Hospital NHS Trust, Warwickshire, is likely to receive the first batches of AstraZeneca’s and Oxford’s coronavirus vaccine on 2nd November. T...

Read More >>
Spain declares second state of emergency amidst surging COVID-19 cases
  Author: Nikita Chaurasia

Spanish Prime Minister, Pedro Sanchez has reportedly announced a nationwide state of emergency owing to soaring COVID-19 cases. According to reliable sources, the country has imposed local nighttime curfew in all regio...

Read More >>
COVID-19: Oxford’s vaccine trials to continue after a subject’s death
  Author: Nikita Chaurasia

The deceased volunteer was reportedly subjected to a placebo and not the actual COVID-19 vaccine. The Brazilian government plans on purchasing the ...

Read More >>
Johnson & Johnson halts COVID-19 vaccine study as participant falls ill
  Author: Nikita Chaurasia

  Johnson & Johnson had initially planned to enroll over 60,000 participants for its phase 3 clinical trials. Experts claim that c...

Read More >>
Diabetes drug metformin recalled over high levels of cancer contaminant
  Author: Nikita Chaurasia

Metformin hydrochloride, a widely used diabetes drug, has reportedly been recalled after manufacturers detected high levels of cancer-causing contaminant in it. According to reliable sources, the latest recall by the U...

Read More >>
Eli Lilly requests for EUA approval from FDA for COVID-19 antibody
  Author: Nikita Chaurasia

Eli Lilly and Company, the American pharmaceutical giant, has reportedly applied for emergency use authorization (EUA) for its potential COVID-19 antibody from the Food & Drug Administration (FDA). Sources with kno...

Read More >>
Bristol Myers Squibb to acquire MyoKardia for access to CVD treatment
  Author: Nikita Chaurasia

  BMS intends to acquire the biotech firm for USD 13 billion. The potential drug of MyoKardia will be sent for FDA approval during Q1...

Read More >>
UnitedHealthcare to expand its Medicare Advantage footprint by 50%
  Author: Nikita Chaurasia

  The company has registered around 6.5 million enrollments in its programs. UnitedHealthcare plans to include additional 3.2 million ...

Read More >>
New research claims sufficiency of vitamin D reduces COVID-19 severity
  Author: Nikita Chaurasia

According to a recent study, COVID-19 patients having sufficient levels of vitamin D, with at least 30 ng/mL of 25-hydroxyvitamin D in their blood, are less likely to witness severe clinical outcomes and deaths. ...

Read More >>
Breast cancer: New treatment claims to reduce recurrence risk by 25%
  Author: Nikita Chaurasia

  The research comprised of patients with increased cellular proliferation and larger tumor size monarchE trials were funded by Eli Li...

Read More >>
Todos, NCL Pharma adds NLC-001 dietary supplement to its joint venture
  Author: Nikita Chaurasia

Todos Medical Ltd., an Israeli in-vitro diagnostic company based, recently announced that NLC Pharma, Inc., its joint venture partner, has added the NLC-001 dietary supplement to their COVID-19 focused-partnership. Thi...

Read More >>
Oxford’s recovery trial to evaluate REGN-COV2 for COVID-19 treatment
  Author: Nikita Chaurasia

According to credible sources, the University of Oxford has announced that it will be initiating the Recovery Trial for testing REGN-COV2, an experimental drug developed for the treatment of the COVID-19 virus. ...

Read More >>
Korean scientists claim energy source of cancer cells are fatty acids
  Author: Nikita Chaurasia

Korean researchers have reportedly discovered that fatty acids are the primary energy source for cancer cells. The study, which was published in the latest issue of the International Journal (Cancer), was confirmed by ...

Read More >>
Duly approved COVID-19 vaccine may take time claim Pharma giants
  Author: Nikita Chaurasia

According to credible sources, nine pharmaceutical organizations including Merck & Co Inc. and Pfizer Inc. have recently issued a joint pledge to not put forward a COVID-19 vaccine until it has been vetted for effi...

Read More >>
Omron Healthcare India profits to surpass USD 21.93 million in FY21
  Author: Nikita Chaurasia

  Omron aims to record 27% spike in revenues by FY21 The revenue growth is attributed to rising cognizance regarding home monitoring s...

Read More >>
Post-COVID-19 inflammatory syndrome puts children’s hearts at risk
  Author: Nikita Chaurasia

New study published in EClinicalMedicine, a journal of The Lancet, shows link between multisystem inflammatory syndrome in children (MIS-C) and COVID-19. Senior author of the medica...

Read More >>
Novan announces first clinical testing for SB206 on molluscum patients
  Author: Nikita Chaurasia

Novan Inc., U.S.-based clinical stage pharmaceutical company, has reportedly announced first patient enrollment in its B-SIMPLE4 pivotal Phase 3 clinical study of SB206, an antiviral gel used for treating molluscum con...

Read More >>
Finally, WHO has some good news for 213 covid-19 impacted countries
  Author: Nikita Chaurasia

The World Health Organization on Wednesday reported that widely available and low-cost corticosteroids can aid covid-19 positive patients suffering from serious symptoms. The body also warned against the use of cortico...

Read More >>
New research claims honeybee venom can inhibit growth of cancer cells
  Author: Nikita Chaurasia

According to a recent study published in NPJ Precision Oncology journal by Harry Perkins Institute of Medical Research, honeybee venom is capable of rapidly destroying HER2-enriched breast cancer cells and triple-negat...

Read More >>
AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
  Author: Mateen Dalal

According to reliable sources, British-Swedish multinational pharmaceutical company AstraZeneca plc will present the much awaited results of the Phase III DAPA-CKD trial of Farxiga in CKD (chronic kidney disease) at ES...

Read More >>
FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
  Author: Mateen Dalal

Abbott Laboratories, a U.S.-based medical devices and healthcare firm, has reportedly received the Emergency Use Authorization (EUA) from the U.S. FDA (Food and Drug Administration) for the detecting COVID-19 virus wit...

Read More >>
FDA grants Fast Track Designation to Polaryx Therapeutics’ PLX-200
  Author: Nikita Chaurasia

Polaryx Therapeutics Inc., a biotechnology firm which develops small molecule therapeutics, has reportedly been granted approval by the U.S. FDA (Food & Drug Administration) of Fast Track Designation for analyzing ...

Read More >>
Salmonella outbreak forces HelloFresh to recall meal kits with onions
  Author: Nikita Chaurasia

HelloFresh, an international meal-kit provider based in Berlin, Germany, has reportedly issued a recall of the products in view of the salmonella infection that has affected 900 Americans, with over 100 hospitalized....

Read More >>
One in three UK firms to cut jobs by third quarter of 2020, poll finds
  Author: Nikita Chaurasia

According to a recent study regarding the economic impact of COVID-19, one in three employers in the United Kingdom are predicted to cut jobs by the third quarter of 2020. Sources close to the matter stated that the su...

Read More >>
Novavax’s COVID-19 vaccine shows promising results in first trial
  Author: Nikita Chaurasia

America-based vaccine development company Novavax Inc. has reportedly announced a potential COVID-19 vaccine which showcased a promising immune response in the early stage of its clinical trial. The trials for phase on...

Read More >>
NHS requests urgent donations of blood plasma from COVID-19 survivors
  Author: Mateen Dalal

According to reliable sources, United Kingdom National Health Service (NHS) has filed an appeal to the individuals recuperated from novel coronavirus to donate blood plasma. The organization apparently intends to treat...

Read More >>
Coronavirus Breaking: New Covid-19 test gives results in just 36 min
  Author: Nikita Chaurasia

The Nanyang Technological University (NTC), Singapore, on Monday, announced that Lee Kong Chain School of Medicine, has demonstrated an astonishing way to accelerate the speed, handling time, and cost of Covid-19 lab t...

Read More >>
OSE Immunotherapeutics receives $228,000 to develop COVID-19 vaccine
  Author: Mateen Dalal

The novel coronavirus outbreak has turned out to be one of the worst disasters the world has witnessed in recent times. At times like this, pharmaceutical companies worldwide have been putting their best foot forward t...

Read More >>
Biolidics lands 5-year licensing deal to develop COVID-19 test kits
  Author: Nikita Chaurasia

Biolidics, a precision medicine medical technology company, headquartered in Singapore, on July 9 inked an agreement with the commercialization arm of the Agency for Science, Technology and Research (A*Star), Accelerat...

Read More >>
Glenmark cuts prices of its COVID-19 drug FabiFlu to USD 1 per pill
  Author: Nikita Chaurasia

As per credible sources, Mumbai-based Glenmark Pharmaceuticals Ltd. recently revealed that it has slashed the price of its coronavirus drug FabiFlu by 27%, from USD 1.37 to USD 1 per pill. ...

Read More >>
40% of COVID-19 patients are asymptomatic, a new CDC report claims
  Author: Mateen Dalal

The ongoing coronavirus pandemic has wreaked havoc worldwide. Dismissed as a slight by the world initially, the virus shocked the scientific and medical communities alike, with the rapid rate of spreading. Very little ...

Read More >>
High likeliness of COVID-19 damaging the brain, claim scientists
  Author: Mateen Dalal

The advent of COVID-19 has turned out to be one of worst disasters the world has seen in recent times. In an attempt to thwart its spread, myriad efforts are being undertaken, along the likes of social distancing, nati...

Read More >>
Scientists say COVID-19 is airborne, ask WHO to revise recommendations
  Author: Nikita Chaurasia

Numerous scientists across the globe have reportedly sent an open letter to WHO (World Health Organization) seeking the health agency to revise recommendations regarding the novel coronavirus. ...

Read More >>
FDA approves ‘Rukobia’ for HIV patients with limited treatment options
  Author: Mateen Dalal

The use of antiretroviral therapies (ART) to battle HIV (Human Immunodeficiency Virus) is one of the great achievements of modern medicine. The ART medications can transform HIV from a fatal infection into a more manag...

Read More >>
HSA: Banned substances found in two weight loss products online
  Author: Nikita Chaurasia

HSA (The Health Sciences Authority of Singapore) has reportedly issued an alert regarding two weight loss products found online which comprise of banned substances and can be harmful to the human health. The agency has...

Read More >>
First batch of TraceTogether tokens released among vulnerable seniors
  Author: Nikita Chaurasia

Reportedly, the first batch of TraceTogether tokens was distributed yesterday among vulnerable seniors who live by their own and do not utilize any digital devices. The functioning of the tokens is like that of the sma...

Read More >>
Sanofi and Translate Bio to jointly produce mRNA Covid-19 vaccine
  Author: Nikita Chaurasia

French multinational pharmaceutical company Sanofi S.A. is reportedly expanding its collaboration with Translate Bio, a U.S-based mRNA therapeutics company to develop a wide range of messenger ribonucleic acid (mRNA) v...

Read More >>
EMA validates use of BAVENCIO for treating Urothelial Carcinoma
  Author: Nikita Chaurasia

German multinational pharmaceutical, chemical, and life sciences company, Merck KGaA, headquartered in Darmstadt, recently declared that the European Medicines Agency (EMA) has approved the review process for the Type II variation application for ...

Read More >>
Spike in COVID cases: Long queues seen at testing clinics in Melbourne
  Author: Nikita Chaurasia

Reportedly, long traffic queues were spotted snaking out of car parks at Northland and Southland shopping centers as people flocked at testing clinics, after the recent spike in COVID-19 cases in Victoria, Melbourne....

Read More >>
Low-dose steroid dexamethasone to be used for treating COVID-19 in U.K.
  Author: Nikita Chaurasia

As reported by credible sources, in a recent development the U.K. government has permitted the state-funded NHS (National Health Service) to use an anti-inflammatory steroid called “dexamethasone” for treat...

Read More >>
Under Armour launches special face masks designed for workout
  Author: Mateen Dalal

In a bid to make working out more convenient during the ongoing pandemic, Under Armour, Inc., has reportedly launched the first-of-kind facial mask designed for the workout which brings hope to runners, cyclists, and a...

Read More >>
UNC School of Medicine announces new kind of test for COVID-19
  Author: Mateen Dalal

With the number of people testing positive for COVID-19 increasing to over 7.5 million, the need for extensively applicable surveillance testing for better understanding of infection rates, particularly the number of i...

Read More >>
J&J to begin human trial of COVID-19 vaccine in U.S. and Belgium
  Author: Mateen Dalal

Johnson & Johnson, a multinational medical device & pharmaceuticals company, has recently announced its plan to commence the human trial of a potential COVID-19 vaccine by the 2nd half of July 2020. The drug ma...

Read More >>
New Wave Holdings Corp. funds Delos Psyche to back LSD research
  Author: Mateen Dalal

New Wave Holdings Corp., a Canadian company that focuses on entertainment and esports facilities, has recently announced that it would support the Delos Psyche Research Group in its research on determining the impact o...

Read More >>
India approves the emergency use of remdesivir for COVID-19 treatment
  Author: Mateen Dalal

India’s Drug Controller General, VG Somani, has reportedly authorized the use of remdesivir for the treatment of coronavirus patients. Remdesivir is a novel drug developed by renowned pharmaceutical firm Gilead S...

Read More >>
Scientists devise method to decrease coronavirus count in plasma, blood
  Author: Mateen Dalal

Ever since COVID-19 has ravaged the globe, claiming more than 3 lakh lives, various research organizations and scientists the world over, have been striving to introduce a vaccine or a medication or a potential method ...

Read More >>
Netsmart introduces unique mobile screening solution for COVID-19
  Author: Mateen Dalal

In the face of the ongoing pandemic spread worldwide, that has disrupted businesses and turned normal lives upside down, companies have been striving to bring about innovative solutions that can ensure people to remain adequately and correctly inf...

Read More >>
First suspected cases of MIS-C under examination in South Korea
  Author: Mateen Dalal

Health authorities in South Korea have lately announced the ongoing medical examination of two children cited as suspected cases of a life-threatening syndrome associated with coronavirus. The two children are apparent...

Read More >>
Teva presents AJOVY’s new data on migraine impact in European adults
  Author: Mateen Dalal

The analysis examines impact of migraine in areas of Spain, France, and the United Kingdom. Migraine has been one of the prominent neurological condit...

Read More >>
Chinese university conducts trials to launch new Covid-19 drug
  Author: Mateen Dalal

Scientists at Peking University in China have successfully conducted tests for a new drug which they claim could help in containing the coronavirus pandemic. Since its outbreak in China, the disease continues to be a m...

Read More >>
Moderna’s Phase 1 vaccine trial produces antibodies against SARS-CoV-2
  Author: Mateen Dalal

Moderna, Inc., an American biotechnology company, recently announced that its coronavirus vaccine candidate has produced protective antibodies among a group of healthy volunteers. E...

Read More >>
Gilead inks non-exclusive licensing pacts with 5 generic drug-makers
  Author: Mateen Dalal

Gilead Sciences, an American biopharmaceutical company, has recently inked non-exclusive licensing pacts with 5 India- and Pakistan-based generic drug-makers. These licensing agreements have been made to increase the s...

Read More >>
South Korea delays school reopening due to new COVID-19 cluster
  Author: Mateen Dalal

South Korea has delayed the process of reopening schools by a week due to the fears of possible 2nd wave of COVID-19 infections. The latest coronavirus cases stem from a new cluster traced to 5 clubs and bars in Itaewon. The number of infe...

Read More >>
Enlivex commences phase II study of Allocetra in COVID-19 patients
  Author: Mateen Dalal

The world has joined forces to develop a vaccine for COVID-19 and companies across the globe are scrambling for the first breakthrough. Since the coronavirus spreads easily and is already weakening the healthcare syste...

Read More >>
Gilead in talks with Indian drug producers to offer patented remdesivir
  Author: Mateen Dalal

Gilead Sciences, an American biopharmaceutical company, has recently engaged in talks with some leading chemical & pharmaceutical companies in countries including India. The discussion has been held on remdesivir, ...

Read More >>